CD8A and neoplasm: Despite the fact that oHSV-4-1BBL treatment could reverse the exhaustion of CD8+ T cells (Figure 4F,G) and extended the survival time of tumor-bearing mice, the pancreatic tumors eventually grew without complete regression (Figure 2C,F).